Anti-Infective Agents Market (2025 - 2030) Size, Share & Trends Analysis Report By Type (Antibacterial, Antiviral, Antifungal & Antiparasitic), By Route Of Administration (Oral, Parenteral), By Distribution Channel, By Region, And Segment Forecasts

Market Segmentation

• Anti-infective Agents Type Outlook (Revenue, USD Million, 2018 - 2030)
  • Antibacterials
    • Cephalosporins
    • Penicillin
    • Fluoroquinolones
    • Macrolides
    • Carbapenem
    • Others
  • Antivirals
  • Antifungals
    • Azoles
    • Echinocandins
    • Polyenes
    • Others
• Anti-infective Agents Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
  • Parenteral
  • Topical
  • Others
• Anti-infective Agents Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospital Pharmacies
  • Retail Pharmacies
  • Others
• Anti-Infective Agents Regional Outlook (Revenue, USD Million; 2018 - 2030)
  • North America
    • North America Type Outlook (Revenue, USD Million, 2018 - 2030)
      • Antibacterials
        • Cephalosporins
        • Penicillin
        • Fluoroquinolones
        • Macrolides
        • Carbapenem
        • Others
      • Antivirals
      • Antifungals
        • Azoles
        • Echinocandins
        • Polyenes
        • Others
    • North America Route of Administration Outlook (Revenue, USD Billion, 2018 - 2030)
    • Parenteral
    • Topical
    • Others
    • North America Distribution Channel Outlook (Revenue, USD Billion, 2018 - 2030)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Others
    • U.S.
      • U.S. Type Outlook (Revenue, USD Billion, 2018 - 2030)
        • Antibacterials
          • Cephalosporins
          • Penicillin
          • Fluoroquinolones
          • Macrolides
          • Carbapenem
          • Others
        • Antivirals
        • Antifungals
          • Azoles
          • Echinocandins
          • Polyenes
          • Others
      • U.S. Route of Administration Outlook (Revenue, USD Billion, 2018 - 2030)
      • Parenteral
      • Topical
      • Others
      • U.S. Distribution Channel Outlook (Revenue, USD Billion, 2018 - 2030)
        • Hospital Pharmacies
        • Retail Pharmacies
        • Others
    • Canada
      • Canada Type Outlook (Revenue, USD Billion, 2018 - 2030)
        • Antibacterials
          • Cephalosporins
          • Penicillin
          • Fluoroquinolones
          • Macrolides
          • Carbapenem
          • Others
        • Antivirals
        • Antifungals
          • Azoles
          • Echinocandins
          • Polyenes
          • Others
      • Canada Route of Administration Outlook (Revenue, USD Billion, 2018 - 2030)
      • Parenteral
      • Topical
      • Others
      • Canada Distribution Channel Outlook (Revenue, USD Billion, 2018 - 2030)
        • Hospital Pharmacies
        • Retail Pharmacies
        • Others
    • Mexico
      • Mexico Type Outlook (Revenue, USD Billion, 2018 - 2030)
        • Antibacterials
          • Cephalosporins
          • Penicillin
          • Fluoroquinolones
          • Macrolides
          • Carbapenem
          • Others
        • Antivirals
        • Antifungals
          • Azoles
          • Echinocandins
          • Polyenes
          • Others
      • Mexico Route of Administration Outlook (Revenue, USD Billion, 2018 - 2030)
      • Parenteral
      • Topical
      • Others
      • Mexico Distribution Channel Outlook (Revenue, USD Billion, 2018 - 2030)
        • Hospital Pharmacies
        • Retail Pharmacies
        • Others
  • Europe
    • Europe Type Outlook (Revenue, USD Billion, 2018 - 2030)
      • Antibacterials
        • Cephalosporins
        • Penicillin
        • Fluoroquinolones
        • Macrolides
        • Carbapenem
        • Others
      • Antivirals
      • Antifungals
        • Azoles
        • Echinocandins
        • Polyenes
        • Others
      • Europe Route of Administration Outlook (Revenue, USD Billion, 2018 - 2030)
        • Parenteral
        • Topical
        • Others
      • Europe Distribution Channel Outlook (Revenue, USD Billion, 2018 - 2030)
        • Hospital Pharmacies
        • Retail Pharmacies
        • Others
    • UK
      • UK Type Outlook (Revenue, USD Billion, 2018 - 2030)
        • Antibacterials
          • Cephalosporins
          • Penicillin
          • Fluoroquinolones
          • Macrolides
          • Carbapenem
          • Others
        • Antivirals
        • Antifungals
          • Azoles
          • Echinocandins
          • Polyenes
          • Others
      • UK Route of Administration Outlook (Revenue, USD Billion, 2018 - 2030)
      • Parenteral
      • Topical
      • Others
      • UK Distribution Channel Outlook (Revenue, USD Billion, 2018 - 2030)
        • Hospital Pharmacies
        • Retail Pharmacies
        • Others
    • Germany
      • Germany Type Outlook (Revenue, USD Billion, 2018 - 2030)
        • Antibacterials
          • Cephalosporins
          • Penicillin
          • Fluoroquinolones
          • Macrolides
          • Carbapenem
          • Others
        • Antivirals
        • Antifungals
          • Azoles
          • Echinocandins
          • Polyenes
          • Others
      • Germany Route of Administration Outlook (Revenue, USD Billion, 2018 - 2030)
      • Parenteral
      • Topical
      • Others
      • Germany Distribution Channel Outlook (Revenue, USD Billion, 2018 - 2030)
        • Hospital Pharmacies
        • Retail Pharmacies
        • Others
    • France
      • France Type Outlook (Revenue, USD Billion, 2018 - 2030)
        • Antibacterials
          • Cephalosporins
          • Penicillin
          • Fluoroquinolones
          • Macrolides
          • Carbapenem
          • Others
        • Antivirals
        • Antifungals
          • Azoles
          • Echinocandins
          • Polyenes
          • Others
      • France Route of Administration Outlook (Revenue, USD Billion, 2018 - 2030)
      • Parenteral
      • Topical
      • Others
      • France Distribution Channel Outlook (Revenue, USD Billion, 2018 - 2030)
        • Hospital Pharmacies
        • Retail Pharmacies
        • Others
    • Italy
      • Italy Type Outlook (Revenue, USD Billion, 2018 - 2030)
        • Antibacterials
          • Cephalosporins
          • Penicillin
          • Fluoroquinolones
          • Macrolides
          • Carbapenem
          • Others
        • Antivirals
        • Antifungals
          • Azoles
          • Echinocandins
          • Polyenes
          • Others
      • Italy Route of Administration Outlook (Revenue, USD Billion, 2018 - 2030)
      • Parenteral
      • Topical
      • Others
      • Italy Distribution Channel Outlook (Revenue, USD Billion, 2018 - 2030)
        • Hospital Pharmacies
        • Retail Pharmacies
        • Others
    • Spain
      • Spain Type Outlook (Revenue, USD Billion, 2018 - 2030)
        • Antibacterials
          • Cephalosporins
          • Penicillin
          • Fluoroquinolones
          • Macrolides
          • Carbapenem
          • Others
        • Antivirals
        • Antifungals
          • Azoles
          • Echinocandins
          • Polyenes
          • Others
      • Spain Route of Administration Outlook (Revenue, USD Billion, 2018 - 2030)
      • Parenteral
      • Topical
      • Others
      • Spain Distribution Channel Outlook (Revenue, USD Billion, 2018 - 2030)
        • Hospital Pharmacies
        • Retail Pharmacies
        • Others
    • Denmark
      • Denmark Type Outlook (Revenue, USD Billion, 2018 - 2030)
        • Antibacterials
          • Cephalosporins
          • Penicillin
          • Fluoroquinolones
          • Macrolides
          • Carbapenem
          • Others
        • Antivirals
        • Antifungals
          • Azoles
          • Echinocandins
          • Polyenes
          • Others
      • Denmark Route of Administration Outlook (Revenue, USD Billion, 2018 - 2030)
      • Parenteral
      • Topical
      • Others
      • Denmark Distribution Channel Outlook (Revenue, USD Billion, 2018 - 2030)
        • Hospital Pharmacies
        • Retail Pharmacies
        • Others
    • Sweden
      • Sweden Type Outlook (Revenue, USD Billion, 2018 - 2030)
        • Antibacterials
          • Cephalosporins
          • Penicillin
          • Fluoroquinolones
          • Macrolides
          • Carbapenem
          • Others
        • Antivirals
        • Antifungals
          • Azoles
          • Echinocandins
          • Polyenes
          • Others
      • Sweden Route of Administration Outlook (Revenue, USD Billion, 2018 - 2030)
      • Parenteral
      • Topical
      • Others
      • Sweden Distribution Channel Outlook (Revenue, USD Billion, 2018 - 2030)
        • Hospital Pharmacies
        • Retail Pharmacies
        • Others
    • Norway
      • Norway Type Outlook (Revenue, USD Billion, 2018 - 2030)
        • Antibacterials
          • Cephalosporins
          • Penicillin
          • Fluoroquinolones
          • Macrolides
          • Carbapenem
          • Others
        • Antivirals
        • Antifungals
          • Azoles
          • Echinocandins
          • Polyenes
          • Others
      • Norway Route of Administration Outlook (Revenue, USD Billion, 2018 - 2030)
      • Parenteral
      • Topical
      • Others
      • Norway Distribution Channel Outlook (Revenue, USD Billion, 2018 - 2030)
        • Hospital Pharmacies
        • Retail Pharmacies
        • Others
    • Rest of Europe
      • Rest of Europe Type Outlook (Revenue, USD Billion, 2018 - 2030)
        • Antibacterials
          • Cephalosporins
          • Penicillin
          • Fluoroquinolones
          • Macrolides
          • Carbapenem
          • Others
        • Antivirals
        • Antifungals
          • Azoles
          • Echinocandins
          • Polyenes
          • Others
      • Rest of Europe Route of Administration Outlook (Revenue, USD Billion, 2018 - 2030)
      • Parenteral
      • Topical
      • Others
      • Rest of Europe Distribution Channel Outlook (Revenue, USD Billion, 2018 - 2030)
        • Hospital Pharmacies
        • Retail Pharmacies
        • Others
  • Asia Pacific
    • Asia Pacific Type Outlook (Revenue, USD Billion, 2018 - 2030)
      • Antibacterials
        • Cephalosporins
        • Penicillin
        • Fluoroquinolones
        • Macrolides
        • Carbapenem
        • Others
      • Antivirals
      • Antifungals
        • Azoles
        • Echinocandins
        • Polyenes
        • Others
    • Asia Pacific Route of Administration Outlook (Revenue, USD Billion, 2018 - 2030)
    • Parenteral
    • Topical
    • Others
    • Asia Pacific Distribution Channel Outlook (Revenue, USD Billion, 2018 - 2030)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Others
    • Japan
      • Japan Type Outlook (Revenue, USD Billion, 2018 - 2030)
        • Antibacterials
          • Cephalosporins
          • Penicillin
          • Fluoroquinolones
          • Macrolides
          • Carbapenem
          • Others
        • Antivirals
        • Antifungals
          • Azoles
          • Echinocandins
          • Polyenes
          • Others
      • Japan Route of Administration Outlook (Revenue, USD Billion, 2018 - 2030)
      • Parenteral
      • Topical
      • Others
      • Japan Distribution Channel Outlook (Revenue, USD Billion, 2018 - 2030)
        • Hospital Pharmacies
        • Retail Pharmacies
        • Others
    • China
      • China Type Outlook (Revenue, USD Billion, 2018 - 2030)
        • Antibacterials
          • Cephalosporins
          • Penicillin
          • Fluoroquinolones
          • Macrolides
          • Carbapenem
          • Others
        • Antivirals
        • Antifungals
          • Azoles
          • Echinocandins
          • Polyenes
          • Others
      • China Route of Administration Outlook (Revenue, USD Billion, 2018 - 2030)
      • Parenteral
      • Topical
      • Others
      • China Distribution Channel Outlook (Revenue, USD Billion, 2018 - 2030)
        • Hospital Pharmacies
        • Retail Pharmacies
        • Others
    • India
      • India Type Outlook (Revenue, USD Billion, 2018 - 2030)
        • Antibacterials
          • Cephalosporins
          • Penicillin
          • Fluoroquinolones
          • Macrolides
          • Carbapenem
          • Others
        • Antivirals
        • Antifungals
          • Azoles
          • Echinocandins
          • Polyenes
          • Others
      • India Route of Administration Outlook (Revenue, USD Billion, 2018 - 2030)
      • Parenteral
      • Topical
      • Others
      • India Distribution Channel Outlook (Revenue, USD Billion, 2018 - 2030)
        • Hospital Pharmacies
        • Retail Pharmacies
        • Others
    • South Korea
      • South Korea Type Outlook (Revenue, USD Billion, 2018 - 2030)
        • Antibacterials
          • Cephalosporins
          • Penicillin
          • Fluoroquinolones
          • Macrolides
          • Carbapenem
          • Others
        • Antivirals
        • Antifungals
          • Azoles
          • Echinocandins
          • Polyenes
          • Others
      • South Korea Route of Administration Outlook (Revenue, USD Billion, 2018 - 2030)
      • Parenteral
      • Topical
      • Others
      • South Korea Distribution Channel Outlook (Revenue, USD Billion, 2018 - 2030)
        • Hospital Pharmacies
        • Retail Pharmacies
        • Others
    • Thailand
      • Thailand Type Outlook (Revenue, USD Billion, 2018 - 2030)
        • Antibacterials
          • Cephalosporins
          • Penicillin
          • Fluoroquinolones
          • Macrolides
          • Carbapenem
          • Others
        • Antivirals
        • Antifungals
          • Azoles
          • Echinocandins
          • Polyenes
          • Others
      • Thailand Route of Administration Outlook (Revenue, USD Billion, 2018 - 2030)
      • Parenteral
      • Topical
      • Others
      • Thailand Distribution Channel Outlook (Revenue, USD Billion, 2018 - 2030)
        • Hospital Pharmacies
        • Retail Pharmacies
        • Others
    • Australia
      • Australia Type Outlook (Revenue, USD Billion, 2018 - 2030)
        • Antibacterials
          • Cephalosporins
          • Penicillin
          • Fluoroquinolones
          • Macrolides
          • Carbapenem
          • Others
        • Antivirals
        • Antifungals
          • Azoles
          • Echinocandins
          • Polyenes
          • Others
      • Australia Route of Administration Outlook (Revenue, USD Billion, 2018 - 2030)
      • Parenteral
      • Topical
      • Others
      • Australia Distribution Channel Outlook (Revenue, USD Billion, 2018 - 2030)
        • Hospital Pharmacies
        • Retail Pharmacies
        • Others
    • Rest of Asia Pacific
      • Rest of Asia Pacific Type Outlook (Revenue, USD Billion, 2018 - 2030)
        • Antibacterials
          • Cephalosporins
          • Penicillin
          • Fluoroquinolones
          • Macrolides
          • Carbapenem
          • Others
        • Antivirals
        • Antifungals
          • Azoles
          • Echinocandins
          • Polyenes
          • Others
      • Rest of Asia Pacific Route of Administration Outlook (Revenue, USD Billion, 2018 - 2030)
      • Parenteral
      • Topical
      • Others
      • Rest of Asia Pacific Distribution Channel Outlook (Revenue, USD Billion, 2018 - 2030)
        • Hospital Pharmacies
        • Retail Pharmacies
        • Others
  • Latin America
    • Latin America Type Outlook (Revenue, USD Billion, 2018 - 2030)
      • Antibacterials
        • Cephalosporins
        • Penicillin
        • Fluoroquinolones
        • Macrolides
        • Carbapenem
        • Others
      • Antivirals
      • Antifungals
        • Azoles
        • Echinocandins
        • Polyenes
        • Others
    • Latin America Route of Administration Outlook (Revenue, USD Billion, 2018 - 2030)
    • Parenteral
    • Topical
    • Others
    • Latin America Distribution Channel Outlook (Revenue, USD Billion, 2018 - 2030)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Others
    • Brazil
      • Brazil Type Outlook (Revenue, USD Billion, 2018 - 2030)
        • Antibacterials
          • Cephalosporins
          • Penicillin
          • Fluoroquinolones
          • Macrolides
          • Carbapenem
          • Others
        • Antivirals
        • Antifungals
          • Azoles
          • Echinocandins
          • Polyenes
          • Others
      • Brazil Route of Administration Outlook (Revenue, USD Billion, 2018 - 2030)
      • Parenteral
      • Topical
      • Others
      • Brazil Distribution Channel Outlook (Revenue, USD Billion, 2018 - 2030)
        • Hospital Pharmacies
        • Retail Pharmacies
        • Others
    • Argentina
      • Argentina Type Outlook (Revenue, USD Billion, 2018 - 2030)
        • Antibacterials
          • Cephalosporins
          • Penicillin
          • Fluoroquinolones
          • Macrolides
          • Carbapenem
          • Others
        • Antivirals
        • Antifungals
          • Azoles
          • Echinocandins
          • Polyenes
          • Others
      • Argentina Route of Administration Outlook (Revenue, USD Billion, 2018 - 2030)
      • Parenteral
      • Topical
      • Others
      • Argentina Distribution Channel Outlook (Revenue, USD Billion, 2018 - 2030)
        • Hospital Pharmacies
        • Retail Pharmacies
        • Others
    • Rest of Latin America
      • Rest of Latin America Type Outlook (Revenue, USD Billion, 2018 - 2030)
        • Antibacterials
          • Cephalosporins
          • Penicillin
          • Fluoroquinolones
          • Macrolides
          • Carbapenem
          • Others
        • Antivirals
        • Antifungals
          • Azoles
          • Echinocandins
          • Polyenes
          • Others
      • Rest of Latin America Route of Administration Outlook (Revenue, USD Billion, 2018 - 2030)
      • Parenteral
      • Topical
      • Others
      • Rest of Latin America Distribution Channel Outlook (Revenue, USD Billion, 2018 - 2030)
        • Hospital Pharmacies
        • Retail Pharmacies
        • Others
  • Middle East & Africa
    • Middle East & Africa Type Outlook (Revenue, USD Billion, 2018 - 2030)
      • Antibacterials
        • Cephalosporins
        • Penicillin
        • Fluoroquinolones
        • Macrolides
        • Carbapenem
        • Others
      • Antivirals
      • Antifungals
        • Azoles
        • Echinocandins
        • Polyenes
        • Others
    • Middle East & Africa Route of Administration Outlook (Revenue, USD Billion, 2018 - 2030)
    • Parenteral
    • Topical
    • Others
    • Middle East & Africa Distribution Channel Outlook (Revenue, USD Billion, 2018 - 2030)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Others
    • South Africa
      • South Africa Type Outlook (Revenue, USD Billion, 2018 - 2030)
        • Antibacterials
          • Cephalosporins
          • Penicillin
          • Fluoroquinolones
          • Macrolides
          • Carbapenem
          • Others
        • Antivirals
        • Antifungals
          • Azoles
          • Echinocandins
          • Polyenes
          • Others
      • South Africa Route of Administration Outlook (Revenue, USD Billion, 2018 - 2030)
      • Parenteral
      • Topical
      • Others
      • South Africa Distribution Channel Outlook (Revenue, USD Billion, 2018 - 2030)
        • Hospital Pharmacies
        • Retail Pharmacies
        • Others
    • Saudi Arabia
      • Saudi Arabia Type Outlook (Revenue, USD Billion, 2018 - 2030)
        • Antibacterials
          • Cephalosporins
          • Penicillin
          • Fluoroquinolones
          • Macrolides
          • Carbapenem
          • Others
        • Antivirals
        • Antifungals
          • Azoles
          • Echinocandins
          • Polyenes
          • Others
      • Saudi Arabia Route of Administration Outlook (Revenue, USD Billion, 2018 - 2030)
      • Parenteral
      • Topical
      • Others
      • Saudi Arabia Distribution Channel Outlook (Revenue, USD Billion, 2018 - 2030)
        • Hospital Pharmacies
        • Retail Pharmacies
        • Others
    • UAE
      • UAE Type Outlook (Revenue, USD Billion, 2018 - 2030)
        • Antibacterials
          • Cephalosporins
          • Penicillin
          • Fluoroquinolones
          • Macrolides
          • Carbapenem
          • Others
        • Antivirals
        • Antifungals
          • Azoles
          • Echinocandins
          • Polyenes
          • Others
      • UAE Route of Administration Outlook (Revenue, USD Billion, 2018 - 2030)
      • Parenteral
      • Topical
      • Others
      • UAE Distribution Channel Outlook (Revenue, USD Billion, 2018 - 2030)
        • Hospital Pharmacies
        • Retail Pharmacies
        • Others
    • Kuwait
      • Kuwait Type Outlook (Revenue, USD Billion, 2018 - 2030)
        • Antibacterials
          • Cephalosporins
          • Penicillin
          • Fluoroquinolones
          • Macrolides
          • Carbapenem
          • Others
        • Antivirals
        • Antifungals
          • Azoles
          • Echinocandins
          • Polyenes
          • Others
      • Kuwait Route of Administration Outlook (Revenue, USD Billion, 2018 - 2030)
      • Parenteral
      • Topical
      • Others
      • Kuwait Distribution Channel Outlook (Revenue, USD Billion, 2018 - 2030)
        • Hospital Pharmacies
        • Retail Pharmacies
        • Others
    • Rest of MEA
      • Rest of MEA Type Outlook (Revenue, USD Billion, 2018 - 2030)
        • Antibacterials
          • Cephalosporins
          • Penicillin
          • Fluoroquinolones
          • Macrolides
          • Carbapenem
          • Others
        • Antivirals
        • Antifungals
          • Azoles
          • Echinocandins
          • Polyenes
          • Others
      • Rest of MEA Route of Administration Outlook (Revenue, USD Billion, 2018 - 2030)
      • Parenteral
      • Topical
      • Others
      • Rest of MEA Distribution Channel Outlook (Revenue, USD Billion, 2018 - 2030)
        • Hospital Pharmacies
        • Retail Pharmacies
        • Others

Report content

Qualitative Analysis

• Industry overview
• Industry trends
• Market drivers and restraints
• Market size
• Growth prospects
• Porter’s analysis
• PESTEL analysis
• Key market opportunities prioritized
• Competitive landscape
  • Company overview
  • Financial performance
  • Product benchmarking
  • Latest strategic developments

Quantitative Analysis

• Market size, estimates, and forecast from 2018 to 2030
• Market estimates and forecast for product segments up to 2030
• Regional market size and forecast for product segments up to 2030
• Market estimates and forecast for application segments up to 2030
• Regional market size and forecast for application segments up to 2030
• Company financial performance